Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02293564 · ClinicalTrials.gov registry record · NA
Open-label Safety Extension Study of Gevokizumab in Erosive Osteoarthritis of the Hand
A NA study, sponsored by Xoma (US).
- Completed
- Registry status
- NA
- Development phase
- 312
- Enrollment target
NCT02293564 is a NA study that has completed, run by Xoma (US). The registered enrollment target is 312 participants.
The verdict
NCT02293564, a NA study, has completed, sponsored by Xoma (US).
- COMPLETED
- Registry status
- NA
- Development phase
- 312 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the long-term safety of gevokizumab in the treatment of active inflammatory, erosive osteoarthritis of the hand.
Interventions
- DRUG gevokizumab
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 312 participants |
| Start Date | 2013-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02293564
The ClinicalTrials.gov registry entry for NCT02293564 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 312 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Xoma (US), which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which gevokizumab is the first listed.
NCT02293564 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02293564 about?
NCT02293564 is a clinical study titled "Open-label Safety Extension Study of Gevokizumab in Erosive Osteoarthritis of the Hand". The purpose of this study is to evaluate the long-term safety of gevokizumab in the treatment of active inflammatory, erosive osteoarthritis of the hand.
What is the current status of trial NCT02293564?
This trial is currently completed. It is a NA study. The enrollment target is 312 participants. The study started on 2013-03.
What interventions are being tested in trial NCT02293564?
The interventions under investigation include: gevokizumab (DRUG).
Who is sponsoring clinical trial NCT02293564?
This trial is sponsored by Xoma (US), which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.